Wu, X <br/><br/>
IL-4 administration exerts preventive effects via suppression of underlying inflammation and TNF-α-induced apoptosis in steroid-induced osteonecrosis.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  May 2016 
 - 1827-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-015-3474-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Caspase 3--metabolism<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical--methods<br/>Glucocorticoids<br/>Inflammation--drug therapy<br/>Interleukin-4--pharmacology<br/>Macrophages--drug effects<br/>Methylprednisolone<br/>Mice, Inbred BALB C<br/>Osteoclasts--drug effects<br/>Osteonecrosis--chemically induced<br/>Recombinant Proteins--pharmacology<br/>STAT1 Transcription Factor--metabolism<br/>Signal Transduction--drug effects<br/>Tartrate-Resistant Acid Phosphatase--blood<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors